Endo Vitd No Screening Healthy

---
name: endo-vitd-no-screening-healthy
description: Recommends against routine 25(OH)D screening and subsequent vitamin D treatment in healthy adults without established indications. Triggered by clinician questions such as "Should I screen for vitamin D deficiency in this healthy adult?" or "Is vitamin D testing indicated for asymptomatic patients?"
---

# Against routine vitamin D screening in healthy adults

## STEP 1 — Gather Information
Collect patient age, presence of established indications for vitamin D testing (e.g., hypocalcemia, hyperparathyroidism, malabsorption, chronic kidney disease, osteoporosis, or medications affecting vitamin D metabolism), and symptoms suggestive of deficiency (e.g., bone pain, proximal muscle weakness). If asymptomatic and no indications, proceed.

## STEP 2 — Rule In / Rule Out
Rule out any established indication for 25(OH)D testing. If an indication is present (e.g., hypocalcemia, malabsorption), screening may be warranted per other guidelines — stop here. If no indication exists, classify as a healthy adult without indications.

## STEP 3 — Classify or Stratify
Classify the patient as a healthy adult without established indications for vitamin D testing. This triggers the recommendation against routine screening.

## STEP 4 — Decide
Do not order a 25(OH)D test. Instead, follow age‑specific guidance for empiric vitamin D supplementation (e.g., against supplementation beyond DRI for adults <75 years) based on other guideline questions.

## Clinical Guardrails / Mimics / Pitfalls
Do not screen based solely on nonspecific symptoms like fatigue or low energy. Avoid treating low 25(OH)D levels without an established indication. Do not apply this recommendation to patients with conditions that alter vitamin D physiology (e.g., CKD, gastric bypass, anticonvulsants).

## Concrete Clinical Example
A 45‑year‑old asymptomatic patient requests vitamin D screening. Review reveals no hypocalcemia, malabsorption, or other indications. The clinician decides against ordering a 25(OH)D test and reassures the patient that routine screening is not recommended.

**Source:** Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2024, https://doi.org/10.1210/clinem/dgae290